|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.210 HKD | -0.69% |
|
-0.55% | -14.47% |
| 11:03am | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 09:28pm | Alphamab Says Phase 3 Study of Breast Cancer Drug Meets Primary Endpoint | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.69% | -0.55% | -12.07% | -22.14% | -14.47% | -20.59% | +6.97% | -41.09% | +97.48% | 10.59B | |
| +2.63% | +3.75% | +20.73% | +16.77% | +8.64% | +44.38% | +162.17% | +420.99% | +1,480.68% | 1,013B | |
| +1.00% | +5.27% | +8.48% | -1.15% | +16.07% | +54.71% | +50.22% | +45.61% | +105.67% | 574B | |
| +1.01% | +1.10% | +12.15% | -0.11% | -0.47% | +18.76% | +65.12% | +97.04% | +279.48% | 397B | |
| -0.37% | +4.97% | +3.74% | -2.42% | -0.34% | +21.24% | +15.95% | -4.01% | +30.42% | 324B | |
| +0.85% | +0.18% | +0.56% | -6.26% | -1.54% | +24.50% | +14.78% | +62.81% | +254.98% | 280B | |
| +2.10% | +4.92% | +6.90% | +0.25% | +10.89% | +25.30% | +33.80% | +45.87% | +61.84% | 273B | |
| +6.05% | +3.44% | +8.47% | -5.33% | +9.22% | +22.51% | +64.47% | +47.26% | +133.54% | 182B | |
| -0.19% | -0.46% | -5.82% | +13.11% | -13.13% | -45.32% | -48.35% | +9.35% | +55.59% | 194B | |
| +4.37% | -2.07% | -5.25% | -13.35% | +3.07% | +15.75% | +62.48% | +83.96% | +50.64% | 151B | |
| +2.83% | +2.39% | +1.92% | -3.64% | +5.64% | +7.46% | -34.07% | -34.48% | -24.28% | 146B | |
| +3.21% | +1.27% | +2.96% | -4.43% | +6.27% | +14.27% | -11.49% | -14.88% | -20.63% | 114B | |
| +2.02% | +0.48% | +1.99% | -9.86% | -2.10% | -1.90% | +30.31% | +129.95% | +390.23% | 111B | |
| +0.38% | -0.18% | +4.21% | +0.07% | -7.76% | -12.01% | -19.70% | -14.17% | +9.80% | 105B | |
| +2.13% | +3.18% | +6.40% | -5.01% | +7.56% | +28.86% | +42.85% | +11.87% | +10.88% | 103B | |
| -1.75% | +0.07% | -5.97% | -21.97% | -9.89% | -2.98% | +87.34% | +74.08% | +484.12% | 77.55B | |
| -0.73% | +6.00% | -3.45% | -11.96% | +4.10% | +15.30% | +10.93% | +33.61% | +10.54% | 49.92B | |
| -0.06% | -0.47% | -11.02% | -16.92% | -21.13% | -14.78% | +2.60% | -35.64% | +225.49% | 45.92B | |
| +1.19% | +0.65% | -3.48% | -10.56% | -3.30% | +28.95% | -29.97% | -33.07% | -59.36% | 40.15B | |
| +3.42% | -0.15% | -4.07% | +12.83% | +10.16% | +98.50% | +370.31% | +209.45% | -35.40% | 39.1B | |
| Average | +1.48% | +2.41% | +1.37% | -4.60% | +0.37% | +16.15% | +43.84% | +54.72% | +177.08% | 211.5B | |
| Weighted average by Cap. | +1.72% | +3.65% | +8.03% | +1.78% | +4.65% | +26.24% | +63.73% | +133.06% | +448.72% |
- Stock Market
- Stocks
- 1093 Stock
- Sector CSPC Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
